Picture of Alphamab Oncology logo

9966 — Alphamab Oncology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapSucker Stock

Brief: Cspc Pharmaceutical Announces Exclusive License Agreement With Jiangsu Alphamab

Aug 23 (Reuters) - CSPC Pharmaceutical Group Ltd  1093.HK :
    * EXCLUSIVE LICENSE AGREEMENT WITH JIANGSU ALPHAMAB FOR
DEVELOPMENT AND COMMERCIALIZATION OF KN026 IN CHINA
    * UNIT TO PAY AN UPFRONT PAYMENT OF RMB150 MILLION &
DEVELOPMENT
MILESTONE PAYMENTS OF UP TO RMB450 MILLION FOR DEAL


Further company coverage:  1093.HK

Recent news on Alphamab Oncology

See all news